Penn Medicine Provider
Pathology and Laboratory Medicine
Lauren Ende Schwartz, MD
Sees patients age 18 and up
Penn Pathology and Laboratory Medicine HUP

About me

  • Director of Quality, Anatomic Pathology, Hospital of the University of Pennsylvania
  • Associate Vice Chair, Quality and Patient Safety
  • Associate Professor of Clinical Pathology and Laboratory Medicine

Dr. Schwartz specializes in Gynecological and Genitourinary Pathology.

Education and training

  • Medical School: New York University School of Medicine
  • Residency: Hospital of the University of Pennsylvania
  • Fellowship: Johns Hopkins Hospital
  • Fellowship: Johns Hopkins Hospital

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Schwartz is a Penn Medicine physician.

Qualifications and experience

My research

Brian D Cortese, Raju Chelluri, Alexander J Skokan, Leilei Xia, David A Ostrowski, Daniel S Roberson, Lauren Schwartz, Daniel J Lee, Tess M Lukowiak, Thomas J Guzzo, S Bruce Malkowicz, Christopher J Miller, R Caleb Kovell. Oncologic control and predictors of urologic reconstruction after Mohs micrographic surgery for low-risk penile malignancy , Int Urol Nephrol, 56(12): 2024,3727-3732


Joep Ma Bogaerts, Miranda P Steenbeek, John-Melle Bokhors, Majke Hd van Bommel, Luca Abete, Francesca Addante, Mariel Brinkhuis, Alicja Chrzan, Fleur Cordier, Mojgan Devouassoux-Shisheboran, Juan Fernández-Pérez, Anna Fischer, C Blake Gilks, Angela Guerriero, Marta Jaconi, Tony G Kleijn, Loes Kooreman, Spencer Martin, Jakob Milla, Nadine Narducci, Chara Ntala, Vinita Parkash, Christophe de Pauw, Joseph T Rabban, Lucia Rijstenberg, Robert Rottscholl, Annette Staebler, Koen Van de Vijver, Gian Franco Zannoni, Monica van Zanten; AI‐STIC Study Group; Joanne A de Hullu, Michiel Simons, Jeroen Awm van der Laak. Assessing the impact of deep-learning assistance on the histopathological diagnosis of serous tubal intraepithelial carcinoma (STIC) in fallopian tubes , J Pathol Clin Res, 10(6): 2024


Jacqueline C Yano Maher, Mary B Zelinski, Kutluk H Oktay, Francesca E Duncan, James H Segars, Marla E Lujan, Hong Lou, Bohyun Yun, Sarina N Hanfling, Lauren E Schwartz, Monica M Laronda, Lisa M Halvorson, Kathleen E O'Neill, Veronica Gomez-Lobo. Classification of Human Ovarian Follicle Morphology: Recommendations of the NICHD-Sponsored Ovarian Nomenclature Workshop , Fertil Steril: 2024


Walker S and Schwartz L. Adult granulosa cell tumor (Abdomen) , 2024 PIP-C Performance Improvement Program in Surgical Pathology (CME eligible), College of American Pathologists: 2024


Kardys A and Schwartz L. Leiomyosarcoma (Ovary) , 2024 PIP-B Performance Improvement Program in Surgical Pathology (CME eligible), College of American Pathologists : 2024


Ramesh R, Alghamdi M, Schwartz L, Reyes C, Dumoff K, Chen S. Integrating Immunohistochemistry and Next Generation Sequencing to Improve Molecular Classification of Endometrial Endometrioid Adenocarcinoma , Laboratory Investigation, 104(3, Supplement): 2024,A1230


Ramesh R, Schwartz L, Chen S, Reyes C, Dumoff K and Alghamdi M. Endometrial Endometrioid Adenocarcinomas of No Specific Molecular Profile (NSMP): Genomic Landscape and Subgrouping , Laboratory Investigation, 104(3, Supplement): 2024,S1232


Rojes de Santiago P, Taylor M, Zhuravlev Y, Schwartz L, Walt D, Burns K and Drapkin R. ORF1p Expression from LINE-1 Occurs in Clear Cell Ovarian Carcinoma Precursors and is Detectable in Patient Serum Samples , Laboratory Investigation, 104(3, supplement): 2024,S1236


Parnaz Daneshpajouhnejad, Casey Morrison, Xiaofeng Zhao, Reba E Daniel, Lauren Schwartz, Kumarasen Cooper, Paul Zhang, Priti Lal. Primary Alveolar Soft-Part Sarcoma (ASPS) of the Prostate: Report of a Deceptive Case , Int J Surg Pathol, 31(7): 2023,1359-1363


Daneshpajouhnejad, P and Schwartz L. High-grade serous carcinoma (Ovary) , 2023 PIP-C Performance Improvement Program in Surgical Pathology (CME eligible), College of American Pathologists.: 2023